Researchers at Baylor College of Medicine, Stanford University School of Medicine and collaborating institutions report in ...

Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and ...

Novo Nordisk said on Wednesday it is aware of 10 deaths and 100 hospitalizations resulting from people taking compounded ...

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked ...

Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including ...

Compounded GLP-1s for Weight Loss: What Are They and Are They Safe? GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...

A Look at Early Customer Experiences and Outcomes" which outlines how customers are achieving positive outcomes with compounded medications through our weight loss program. Early customer results ...

Hims & Hers today released a white paper on how its customers are thriving and seeing meaningful results through ... outcomes with compounded medications through our weight loss program.

The research also suggests that Hims & Hers’ weight loss offering is sustainable, allowing its customers to stay on their treatments and achieve lasting results. Only 13% of compounded GLP-1 ...